GluEsk (Glutamate & Esketamine study)
The study involves a screening visit (under 1 hour, in person at Warneford Hospital, OX3 7JX, or remotely via Teams), and two research visits (each around 3 hours at the John Radcliffe Hospital, OX3 9DU). On each of these visits you will receive esketamine or placebo via a nasal spray. We will then use an MRS scanner to observe any changes in glutamate levels.
For information in confidence, with no obligation to participate, please contact our research team:
Email sylvana.vilca-melendez@psych.ox.ac.uk or call 01865 618238
Ethics Approval Reference: R90468/RE001
We are looking for
Healthy individuals aged 18-50, who are not pregnant, and have never taken ketamine or phencyclidine (PCP), including recreationally.
Expenses
You will receive £120 for your time, and reasonable travel expenses will be reimbursed.